Success Metrics

Clinical Success Rate
85.0%

Based on 51 completed trials

Completion Rate
85%(51/60)
Active Trials
5(7%)
Results Posted
82%(42 trials)
Terminated
9(13%)

Phase Distribution

Ph phase_1
7
10%
Ph phase_2
16
22%
Ph phase_3
25
35%
Ph phase_4
9
13%
Ph not_applicable
4
6%

Phase Distribution

7

Early Stage

16

Mid Stage

34

Late Stage

Phase Distribution61 total trials
Phase 1Safety & dosage
7(11.5%)
Phase 2Efficacy & side effects
16(26.2%)
Phase 3Large-scale testing
25(41.0%)
Phase 4Post-market surveillance
9(14.8%)
N/ANon-phased studies
4(6.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

82.3%

51 of 62 finished

Non-Completion Rate

17.7%

11 ended early

Currently Active

5

trials recruiting

Total Trials

72

all time

Status Distribution
Active(5)
Completed(51)
Terminated(11)
Other(5)

Detailed Status

Completed51
Terminated9
Recruiting5
unknown5
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
72
Active
5
Success Rate
85.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (11.5%)
Phase 216 (26.2%)
Phase 325 (41.0%)
Phase 49 (14.8%)
N/A4 (6.6%)

Trials by Status

recruiting57%
terminated913%
withdrawn23%
completed5171%
unknown57%

Recent Activity

Clinical Trials (72)

Showing 20 of 72 trialsScroll for more
NCT06866691Phase 4

Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide

Recruiting
NCT01345058Phase 3

Add on Lacosamide Versus High Dose Monotherapy

Completed
NCT05603702Phase 1

STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis

Recruiting
NCT07412132Phase 3

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

Recruiting
NCT03196466

Population Pharmacokinetics of Antiepileptic in Pediatrics

Completed
NCT04627285Phase 3

A Study to Test the Long-term Use of Oral Lacosamide in Pediatric Study Participants Who Completed NCT01964560 (EP0034) or NCT00938912 (SP848) and Received Lacosamide Treatment

Completed
NCT06969417Not Applicable

Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia

Recruiting
NCT06851910

Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia

Recruiting
NCT05510856Phase 4

Comparative Clinical Study Evaluating the Possible Efficacy of Duloxetine, Gabapentin and Lacosamide on Oxaliplatin-Induced Peripheral Neuropathy in Cancer Patients

Completed
NCT00546351Phase 3

Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.

Completed
NCT00220337Phase 3

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

Completed
NCT05422664

Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy

Unknown
NCT02582866Phase 3

A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994

Completed
NCT03436433Phase 2

Seizure Prophylaxis in Patients With Glioma or Brain Metastasis

Terminated
NCT02710890Phase 2

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.

Completed
NCT03777956Phase 2

The Effect of Lacosamide in Peripheral Neuropathic Pain

Terminated
NCT01964560Phase 3

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

Completed
NCT05291455Phase 3

Lacosamide in Neonatal Status Epilepticus

Unknown
NCT00938912Phase 2

An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy

Completed
NCT03632915

Pharmacokinetics of Antiepileptics in Patients on CRRT

Completed

Drug Details

Intervention Type
DRUG
Total Trials
72